CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 4 Open-market sale Chief Medical Officer sold 19,175 shares at $18.12 ($347,405)
- 4 Open-market sale Chief Medical Officer sold 19,175 shares at $20.81 ($399,055)
- 4 Open-market sale Chief Medical Officer sold 57,308 shares at an average $18.00 ($1,031,769)
- 4 Open-market sale Chief Medical Officer sold 38,567 shares at an average $18.09 ($697,763)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 10,000 shares at an average $22.96 ($229,642)
- 4 Open-market sale Director sold 4,377 shares at $31.54 ($138,063)
- 4 Open-market sale 10% owner sold 4,377 shares at $31.54 ($138,063)
- 4 Open-market sale Chief Medical Officer sold 10,000 shares at an average $29.61 ($296,137)
- 4 Open-market sale Vice President, Finance sold 1,343 shares at an average $31.26 ($41,981)
- 4 Open-market sale Chief Medical Officer sold 10,000 shares at an average $27.00 ($270,026)
- 4 Open-market sale Chief Development Officer sold 15,000 shares at an average $27.00 ($404,958)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 16 · 301 filings